Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 779
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
for
SCLC
Location: Buffalo NY, Cleveland OH, Pittsburgh PA, Detroit MI,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06179069
Phase 1, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Location: Buffalo NY, Cleveland OH, Philadelphia PA, The Bronx NY,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 2 - 40
Code: NCT05634369
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
for
Cancer Survivor, Obesity, Overweight, Prostate Adenocarcinoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: Male
Age: 18+
Code: NCT03880422
Recruiting
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
for
Ovarian Clear Cell Adenocarcinoma,
Location: Buffalo NY, Houston TX
Sponsor: Roswell Park Cancer Institute
Sex: Female
Age: 18+
Code: NCT05231122
Phase 2, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Buffalo NY, Philadelphia PA, New Brunswick NJ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase 2, Recruiting
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
for
Acute Lymphoblastic Leukemia, Pediatric
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 3 - 9
Code: NCT06074666
Recruiting
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
for
Acute Lymphocytic Leukemia
Location: Buffalo NY, Bronx NY, Houston TX
Sponsor: Callisto Pharmaceuticals
Sex: All
Age: 15+
Code: NCT00271063
Phase 1, Phase 2, Recruiting
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT04511039
Phase 1, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT06206863
Recruiting
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
for
Metastatic Breast Cancer, Triple Negative Breast Cancer,
Location: Buffalo NY, Carmel IN, Indianapolis IN, Lexington KY,
Sponsor: Kathy Miller
Sex: All
Age: 18+
Code: NCT05846789
Phase 2, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Buffalo NY, Wilmington DE, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)